Literature DB >> 15885123

Differential expression of regulator of G-protein signalling transcripts and in vivo migration of CD4+ naïve and regulatory T cells.

Fabien Agenès1, Nabil Bosco, Laurent Mascarell, Sabrina Fritah, Rod Ceredig.   

Abstract

The immune response of T lymphocytes to pathogens is initiated in draining secondary lymphoid organs, and activated cells then migrate to the site of infection. Thus, control of naive and regulatory CD4+ T-cell migration is crucial; however, it is poorly understood in physiological and pathological conditions. We found that CD4+ subpopulations displayed characteristic regulator of G-protein signalling (RGS) gene expression profiles. Regulatory T cells express higher levels of RGS1, RGS9 and RGS16 than naive cells. These genes are up-regulated upon cell activation and their level of expression correlates with in vivo cell migration. Using parabiosis, we showed that regulatory T lymphocytes migrate less than naive T cells and that migrant naive T cells express even lower RGS levels than their static counterparts. Our results show an inverse correlation between the capacity to migrate and the levels of RGS1, RGS9 and RGS16 for both naive and regulatory T cells. Taken together, these results suggest a role for RGS molecules in chemokine-induced lymphocyte migration and demonstrate the peculiarity of regulatory T cells in terms of phenotype and migration ability, providing new insights into their function.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15885123      PMCID: PMC1782143          DOI: 10.1111/j.1365-2567.2005.02146.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  32 in total

1.  Homeostasis and anergy of CD4(+)CD25(+) suppressor T cells in vivo.

Authors:  Marc A Gavin; Sally R Clarke; Ella Negrou; Alena Gallegos; Alexander Rudensky
Journal:  Nat Immunol       Date:  2001-12-10       Impact factor: 25.606

2.  CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor.

Authors:  Rebecca S McHugh; Matthew J Whitters; Ciriaco A Piccirillo; Deborah A Young; Ethan M Shevach; Mary Collins; Michael C Byrne
Journal:  Immunity       Date:  2002-02       Impact factor: 31.745

Review 3.  Foxp3 and natural regulatory T cells: key to a cell lineage?

Authors:  Fred Ramsdell
Journal:  Immunity       Date:  2003-08       Impact factor: 31.745

4.  Cyclosporin A therapy differently affects immunological-relevant gene expression following immunization.

Authors:  Laurent Mascarell; Paolo Truffa-Bachi
Journal:  Immunol Lett       Date:  2002-11-01       Impact factor: 3.685

5.  Skin-homing CLA+ T cells and regulatory CD25+ T cells represent major subsets of human peripheral blood memory T cells migrating in response to CCL1/I-309.

Authors:  Lucia Colantonio; Andrea Iellem; Francesco Sinigaglia; Daniele D'Ambrosio
Journal:  Eur J Immunol       Date:  2002-12       Impact factor: 5.532

6.  Role of regulator of G protein signaling 16 in inflammation-induced T lymphocyte migration and activation.

Authors:  Eric Lippert; David L Yowe; Jose-Angel Gonzalo; J Paul Justice; Jeremy M Webster; Eric R Fedyk; Martin Hodge; Cheryl Miller; Jose-Carlos Gutierrez-Ramos; Francisco Borrego; Andrea Keane-Myers; Kirk M Druey
Journal:  J Immunol       Date:  2003-08-01       Impact factor: 5.422

7.  Peripheral expansion of thymus-derived regulatory cells in anti-myelin basic protein T cell receptor transgenic mice.

Authors:  Shohei Hori; Matthias Haury; Juan J Lafaille; Jocelyne Demengeot; António Coutinho
Journal:  Eur J Immunol       Date:  2002-12       Impact factor: 5.532

8.  Homeostasis of peripheral CD4+ T cells: IL-2R alpha and IL-2 shape a population of regulatory cells that controls CD4+ T cell numbers.

Authors:  Afonso R M Almeida; Nicolas Legrand; Martine Papiernik; António A Freitas
Journal:  J Immunol       Date:  2002-11-01       Impact factor: 5.422

9.  RGS13 regulates germinal center B lymphocytes responsiveness to CXC chemokine ligand (CXCL)12 and CXCL13.

Authors:  Geng-Xian Shi; Kathleen Harrison; Gaye Lynn Wilson; Chantal Moratz; John H Kehrl
Journal:  J Immunol       Date:  2002-09-01       Impact factor: 5.422

10.  Cutting edge: the B cell chemokine CXC chemokine ligand 13/B lymphocyte chemoattractant is expressed in the high endothelial venules of lymph nodes and Peyer's patches and affects B cell trafficking across high endothelial venules.

Authors:  Yukihiko Ebisuno; Toshiyuki Tanaka; Naotoshi Kanemitsu; Hidenobu Kanda; Kazuhito Yamaguchi; Tsuneyasu Kaisho; Shizuo Akira; Masayuki Miyasaka
Journal:  J Immunol       Date:  2003-08-15       Impact factor: 5.422

View more
  23 in total

1.  RGS3 controls T lymphocyte migration in a model of Th2-mediated airway inflammation.

Authors:  Jesse W Williams; Douglas Yau; Nan Sethakorn; Jacob Kach; Eleanor B Reed; Tamson V Moore; Judy Cannon; Xiaohua Jin; Heming Xing; Anthony J Muslin; Anne I Sperling; Nickolai O Dulin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-09-27       Impact factor: 5.464

2.  Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia.

Authors:  Huining Kang; I-Ming Chen; Carla S Wilson; Edward J Bedrick; Richard C Harvey; Susan R Atlas; Meenakshi Devidas; Charles G Mullighan; Xuefei Wang; Maurice Murphy; Kerem Ar; Walker Wharton; Michael J Borowitz; W Paul Bowman; Deepa Bhojwani; William L Carroll; Bruce M Camitta; Gregory H Reaman; Malcolm A Smith; James R Downing; Stephen P Hunger; Cheryl L Willman
Journal:  Blood       Date:  2009-10-30       Impact factor: 22.113

Review 3.  Structure, function, and localization of Gβ5-RGS complexes.

Authors:  Vladlen Z Slepak
Journal:  Prog Mol Biol Transl Sci       Date:  2009-10-07       Impact factor: 3.622

4.  Using gene expression to improve the power of genome-wide association analysis.

Authors:  Yen-Yi Ho; Emily C Baechler; Ward Ortmann; Timothy W Behrens; Robert R Graham; Tushar R Bhangale; Wei Pan
Journal:  Hum Hered       Date:  2014-07-30       Impact factor: 0.444

5.  Impact of the TCR signal on regulatory T cell homeostasis, function, and trafficking.

Authors:  Joong Kyu Kim; Mark Klinger; Jonathan Benjamin; Yuanyuan Xiao; David J Erle; Dan R Littman; Nigel Killeen
Journal:  PLoS One       Date:  2009-08-11       Impact factor: 3.240

6.  Up-regulation of proliferative and migratory genes in regulatory T cells from patients with metastatic castration-resistant prostate cancer.

Authors:  Ngar-Yee Huen; Alan Lap-Yin Pang; Jo A Tucker; Tin-Lap Lee; Matteo Vergati; Caroline Jochems; Chiara Intrivici; Vittore Cereda; Wai-Yee Chan; Owen M Rennert; Ravi A Madan; James L Gulley; Jeffrey Schlom; Kwong Y Tsang
Journal:  Int J Cancer       Date:  2013-02-12       Impact factor: 7.396

Review 7.  R4 Regulator of G Protein Signaling (RGS) Proteins in Inflammation and Immunity.

Authors:  Zhihui Xie; Eunice C Chan; Kirk M Druey
Journal:  AAPS J       Date:  2015-11-23       Impact factor: 4.009

Review 8.  R4 RGS proteins: regulation of G-protein signaling and beyond.

Authors:  Geetanjali Bansal; Kirk M Druey; Zhihui Xie
Journal:  Pharmacol Ther       Date:  2007-10-05       Impact factor: 12.310

9.  Interleukin-17A promotes the growth of human germinal center derived non-Hodgkin B cell lymphoma.

Authors:  Elisa Ferretti; Emma Di Carlo; Emanuela Ognio; Carla Guarnotta; Francesco Bertoni; Anna Corcione; Ignazia Prigione; Giulio Fraternali-Orcioni; Domenico Ribatti; Jean Louis Ravetti; Maurilio Ponzoni; Claudio Tripodo; Vito Pistoia
Journal:  Oncoimmunology       Date:  2015-06-19       Impact factor: 8.110

10.  DOCK8 enforces immunological tolerance by promoting IL-2 signaling and immune synapse formation in Tregs.

Authors:  Erin Janssen; Sudha Kumari; Mira Tohme; Sumana Ullas; Victor Barrera; Jeroen Mj Tas; Marcela Castillo-Rama; Roderick T Bronson; Shariq M Usmani; Darrell J Irvine; Thorsten R Mempel; Raif S Geha
Journal:  JCI Insight       Date:  2017-10-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.